Tricuspid Atresia
10
2
2
6
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
20.0%
2 terminated out of 10 trials
75.0%
-11.5% vs benchmark
0%
0 trials in Phase 3/4
50%
3 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (10)
Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular Grafts
NIRS in Congenital Heart Defects - Correlation With Echocardiography
Methacetin Breath Test in Patients With Liver Disease Secondary to Heart Disease
Global and Regional Myocardial Strain and Power Output In Patients With Single Ventricles Using Novel MRI Techniques
Impact of Vitamin C on Endothelial Function and Exercise Capacity in Fontan-Palliated Patients
Biomarker Study for Heart Failure in Children With Single Ventricle Physiology
Sildenafil After the Fontan Operation
Liothyronine in Children With Single Ventricle Congenital Cardiac Malformations Undergoing the Fontan Procedure
Study of Placebo or Bosentan to Treat Patients With Single Ventricle Physiology.
Understanding Dexmedetomidine In Infants Post-Operative From Cardiac Surgery